RealTalk MS

Episode 156: Managing Cognitive Dysfunction in MS with Dr. Meghan Beier


Whether you call it brain fog, cog-fog, or you don't happen to have a name for it, cognitive dysfunction affects more than half of all the people with MS.

Joining me once again is Dr. Meghan Beier, a Rehabilitation Neuropsychologist and Assistant Professor of Physical Medicine at the Johns Hopkins University School of Medicine. Dr. Beier specializes in cognitive rehabilitation and neuropsychological assessment and intervention and she's back to answer more of our questions about managing the cognitive issues typically associated with MS.

Dr. Meghan Beier

We're also talking about Kesimpta (ofatumumab), the high-efficacy b-cell disease-modifying therapy that just received FDA approval.

We'll tell you about the case study of a patient who lost their vaccination immunity to the Varicella-Zoster virus (causes chickenpox & shingles) after receiving their first Ocrevus infusion.

We'll give you the details about the generic for Tecfidera that's going to be available in just a few weeks. And we'll tell you why the U.S. Department of Justice is suing Teva, the manufacturer of Copaxone.

We'll share all the details and let you know where to register for the National MS Society's Black MS Experience Summit.

And we'll tell you how a research team from Facebook (yup — you read that right!) and New York University is hoping to speed up MRI exams.

We have a lot to talk about! Are you ready for RealTalk MS??!

We're trending!  :22

FDA approves ofatumumab (Kesimpta) for treating relapsing-remitting MS and active secondary-progressive MS  3:53

Patient loses vaccination immunity for Varicella-Zoster virus after Ocrevus infusion    5:44

Generic for Tecfidera will be available in September  8:25

U.S. Department of Justice sues Coaxone manufacturer, Teva  9:18

National MS Society to convene the Black MS Experience Summit  12:24

Facebook & New York University research team develop artificial intelligence technology that will speed up MRI exams  13:26

My Interview with Dr. Meghan Beier  15:48

Share this episode  29:38

Leave a rating & review  29:58

Please Support the National MS Society COVID-19 Response Fund  30:22

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email:  https://realtalkms.com/156

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

Varicella-Zoster Immunity Loss in Multiple Sclerosis Patient Treated with Ocrelizumab

National MS Society Black MS Experience Summit

National MS Society COVID-19 Response Fund

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 156
Hosted By: Jon Strum
Guests: Dr. Meghan Beier

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, Tecfidera, Ocrevus, Kesimpta, Ofatumumab, RealTalkMS